%s1 / %s2

Playlist: Kristin Espeland Gourlay's Portfolio

Future Doc Peter Kaminski practices suturing on a pig's foot. Credit: Kristin Gourlay
Image by: Kristin Gourlay 
Future Doc Peter Kaminski practices suturing on a pig's foot.
No text

Featured

Killer Drugs: Tackling Opioid Addiction and Overdose

From Kristin Espeland Gourlay | 56:57

Prescription painkillers like OxyContin have flooded the market. They're incredibly addictive, and once people are hooked, the habit gets expensive. More and more are turning to the cheaper alternative, heroin. And now, more people die every year from accidental opioid (painkillers and heroin) overdoses than any other kind of accident, including car accidents. But there's hope: an overdose antidote called naloxone is becoming increasingly available. And more members of the community who might not typically have been talking are coming together to try to solve the problem. Killer Drugs, a one-hour documentary, explores the rise in opioid addiction and overdose deaths, what it's like for first responders and others on the front lines of the crisis, how communities are responding, and addicts recovering.

Close_up_of_oxycodone_pill_bottle_small

Drug overdose has become the leading cause of accidental death, and many public health, medical, and law enforcement officials are calling it an epidemic. Many of us either know someone who has been affected by addiction, in particular to opioid painkillers like OxyContin or to heroin. How did it come to this? Who is affected? And what’s being done to address the problem?

This hour-long documentary attempts to answer these questions. We dive deep into the world of addiction and recovery, hearing directly from users and overdose survivors. We explore the epidemiology of overdose with a researcher who studies drug abuse and overdose like you would a disease outbreak. And we ride along with police officers in Rhode Island and Massachusetts; in the former, they’re considering equipping police with an overdose antidote called Narcan, and in the latter, they’ve already done it and are saving lives.

We also learn about additional efforts to prevent addiction and overdose from the doctors who prescribe painkillers to the policy experts who are looking for ways the state and other organizations can battle the problem. And we check in with addicts in recovery about what it takes to get sober.

The documentary takes place in New England but references to place are minimal; it would be relevant for listeners almost anywhere in the country.

We tell the story through scenes and characters, music and moments, and rigorous reporting.

All music used in this documentary is copyright free.

Her Newborn In Withdrawal, A Young Mother Faces Her Own Recovery

From Kristin Espeland Gourlay | Part of the Newborns in Withdrawal series | 06:47

More babies are being born dependent on the opioid drugs their pregnant mothers were taking. Their condition, called neonatal abstinence syndrome, sometimes requires hospital stays and powerful medications. But there's hope in this story of a newborn going through withdrawal and a young mother trying to make a new life for him in recovery.

April_23_2014_003_small More babies are being born dependent on the opioid drugs their pregnant mothers were taking. Their condition, called neonatal abstinence syndrome, sometimes requires hospital stays and powerful medications. But there's hope in this story of a newborn going through withdrawal and a young mother trying to make a new life for him in recovery.

At the Crossroads, Part 1: A Tale of Two Epidemics

From Kristin Espeland Gourlay | Part of the At the Crossroads: The Rise of Hepatitis C and the Fight to Stop It series | 07:55

Baby boomers make up the majority of the estimated five million people who have hepatitis C. Most caught the disease – from sharing needles, or a blood transfusion - years before we even knew about the virus. And long before we learned to keep it out of our blood supply. It can take decades before symptoms emerge. Now their liver disease is so advanced, a wave of boomers are getting sick and dying from the disease. But new infections are on the rise among young adults, mainly those who inject drugs. More than a dozen states have reported a 200 percent increase in new cases in the past couple of years. Call it a second boom of hepatitis C infections, a second epidemic quietly on the rise.

Acos__11__small

One infectious disease – Ebola – is dominating the headlines now. But there’s another that affects far more people around the world, including here in the U.S.

Baby boomers make up the majority of the estimated five million people who have hepatitis C. Most caught the disease – from sharing needles, or a blood transfusion - years before we even knew about the virus. And long before we learned to keep it out of our blood supply. It can take decades before symptoms emerge. Now their liver disease is so advanced, a wave of boomers are getting sick and dying from the disease.

But new infections are on the rise among young adults, mainly those who inject drugs. More than a dozen states have reported a 200 percent increase in new cases in the past couple of years. Call it a second boom of hepatitis C infections, a second epidemic quietly on the rise.

“And although it’s scary to look at this tidal wave of cirrhosis and end stage liver disease and liver cancer ahead of us, it’s a phenomenal and very unique opportunity in US history, in the global history, to say, you know what, we see this ahead, let’s come together now, let’s do something now," says one clinician who treats patients with hepatitis C.

At The Crossroads, Part 2: Finding Hep C Infections Before It's Too Late

From Kristin Espeland Gourlay | Part of the At the Crossroads: The Rise of Hepatitis C and the Fight to Stop It series | 06:43

How do you stop an epidemic? Keep the people who are sick from infecting more people. Isolate them if you have to, treat them, and cure them. Epidemic over. But what if you don’t know who’s sick? What if the person who’s still infectious doesn’t know it either, and probably won’t notice any symptoms for decades? That’s what has happened with hepatitis C. This virus slowly attacks the liver. It’s often 20 years or more before someone who’s infected notices anything wrong. Meanwhile, the infection scars the liver. And that could lead to cirrhosis or even liver cancer. Most of the estimated five million Americans who have chronic hepatitis C are somewhere on this spectrum of sickness right now.

Next in the series “At the Crossroads: Hepatitis C On The Rise And The Fight To Stop It,” we check in on the race to find infections before it’s too late.

Riprstory2graphic1 How do you stop an epidemic? Keep the people who are sick from infecting more people. Isolate them if you have to, treat them, and cure them. Epidemic over.

But what if you don’t know who’s sick? What if the person who’s still infectious doesn’t know it either, and probably won’t notice any symptoms for decades?

That’s what has happened with hepatitis C. This virus slowly attacks the liver. It’s often 20 years or more before someone who’s infected notices anything wrong. Meanwhile, the infection scars the liver. And that could lead to cirrhosis or even liver cancer. Most of the estimated five million Americans who have chronic hepatitis C are somewhere on this spectrum of sickness right now.
                                                                    
Next in the series “At the Crossroads: Hepatitis C On The Rise And The Fight To Stop It,” we check in on the race to find infections before it’s too late.

But first, let’s go back. Before the scarring, before the story’s final chapters. To where the story began, for one person.

At The Crossroads, Part 3: As Old Hepatitis C Treatment Fades Out, New Treatments Stoke Hope

From Kristin Espeland Gourlay | Part of the At the Crossroads: The Rise of Hepatitis C and the Fight to Stop It series | 07:52

In just a few weeks, another pharmaceutical company will likely win FDA approval for a new drug to cure hepatitis C. That makes three breakthrough medications hitting the market in less than a year. It’s big news for the estimated five million Americans living with chronic hepatitis C, because some have been waiting decades for a cure.

Next in the series “At The Crossroads: The Rise of Hepatitis C and the Fight to Stop it,” health care reporter Kristin Gourlay has the story of why one man waited so long for treatment.

Here's part of the reason: interferon. Until December 2013, the only treatment for hepatitis C was a drug called interferon. It mimics the body’s natural defense system. Doctors use it to stop viruses and even cancerous tumors. But pharmaceutically speaking, it’s like a bull in a china shop. It might stomp out a virus, but in the process break something important.

Number_of_hep_c_ppl_us_small In just a few weeks, another pharmaceutical company will likely win FDA approval for a new drug to cure hepatitis C. That makes three breakthrough medications hitting the market in less than a year. It’s big news for the estimated five million Americans living with chronic hepatitis C, because some have been waiting decades for a cure.

Next in our series “At The Crossroads: The Rise of Hepatitis C and the Fight to Stop it,” health care reporter Kristin Gourlay has the story of why one man waited so long for treatment.

At The Crossroads, Part 5: The Uncomfortable Math Of Hep C Treatment

From Kristin Espeland Gourlay | Part of the At the Crossroads: The Rise of Hepatitis C and the Fight to Stop It series | 08:30

What’s the price of a human life? Many of us would say each life is priceless. But health economists sometimes have a number in mind.

Number_of_hep_c_ppl_us_small In this part of our series “At the Crossroads: The Rise of Hepatitis C and The Fight To Stop It,” we'll tell you that - and more. We go beyond the high price of new hepatitis C drugs  to ask: how much is too much? Are these new drugs cost effective? And what the heck is a "quality adjusted life year" anyway?

Reporter Kristin Gourlay calls in reinforcements to help her walk through the moral math.

At The Crossroads, Part 6: Veterans Harder Hit By Hep C

From Kristin Espeland Gourlay | Part of the At the Crossroads: The Rise of Hepatitis C and the Fight to Stop It series | 04:02

In our ongoing series about hepatitis C, we look now at one of the hardest hit populations: veterans.

Sanders_hearing_hands_open_small Hep C is three times more prevalent among vets than in the general population. The Veterans Health Administration has the country’s largest hepatitis C screening and treatment program in the country. But that program is struggling to pay for new treatments – and the rising number of veterans who need them.

Part 7: Behind Bars, Hep C Takes a Toll on Inmates, and Budgets

From Kristin Espeland Gourlay | Part of the At the Crossroads: The Rise of Hepatitis C and the Fight to Stop It series | 08:39

Rhode Island’s prisons are grappling with a dilemma. Hundreds of inmates have hepatitis C. New drugs can cure it. But they’re so expensive the department of corrections can’t afford them for every inmate who’s sick.

Medium_security_prison_in_cranston_ri_small Rhode Island’s prisons are grappling with a dilemma. Hundreds of inmates have hepatitis C. New drugs can cure it. But they’re so expensive the department of corrections can’t afford them for every inmate who’s sick.

Part 8: Fueled By Opioid Abuse, New Hep C Infections On The Rise

From Kristin Espeland Gourlay | Part of the At the Crossroads: The Rise of Hepatitis C and the Fight to Stop It series | 08:54

In 2014, tens of thousands of Americans died from accidental drug overdoses. Many more remain addicted to prescription painkillers and heroin. For those who inject the drugs, there’s another risk: hepatitis C.
In the final story in our series “At the Crossroads,” we meet a team of outreach workers determined to find new infections before it’s too late.

Testing_small In 2014, tens of thousands of Americans died from accidental drug overdoses. Many more remain addicted to prescription painkillers and heroin. For those who inject the drugs, there’s another risk: hepatitis C. In the final story in our series “At the Crossroads,” we meet a team of outreach workers determined to find new infections before it’s too late.

Learning To Respect A Patient's Wishes At The End Of Life

From Kristin Espeland Gourlay | 06:53

The nation spends billions of dollars caring for patients during the last few months of life. But all that spending isn’t necessarily helping us live longer or better.

Dnr_bracelet_small The nation spends billions of dollars caring for patients during the last few months of life. But all that spending isn’t necessarily helping us live longer or better. Talking about dying is difficult for most people, including doctors. But can they learn a better way to help patients nearing the end of their lives? Can health care systems learn to respect those wishes? Here’s one experiment to find out.

I Can't Get To You: A Birth Story

From Kristin Espeland Gourlay | 04:04

This is a story for my son, whose birth was supposed to be completely normal. It was anything but. And then they separated us. (Produced for the KCRW Annual Radio Race, 2016 - theme: "out of reach")

Kristin_reunite_with_mag_small On a summer morning in July three years ago, I was getting ready to go to work when my water broke. We headed to the hospital. And after laboring for a few hours, doctors said I needed an emergency C-section. When they pulled my son out, he wasn't breathing. And that's when my world turned upside down. I decided to go back and review the medical records from that day, interview those who were there, to do my own reporting about the worst - and best - day of my life.